You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Neoadjuvant
  • Axitinib plus Toripalimab
  • radical nephrectomy
  • (no location specified)
Feb 12, 2023

Immune Checkpoint Inhibitors in Genitourinary Malignancies

Suspended
  • Carcinoma, Renal Cell
  • Carcinoma, Urothelial
  • Immune cell and CTC detection procedures
  • Durham, North Carolina
    Duke University Medical Center
Nov 11, 2022

Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

Recruiting
  • Non-clear Renal Cell Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 13, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

From Clear Cell Renal Cell Carcinoma

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Urinary sample
  • Saint-Étienne, France
    Chu Saint-Etienne
Jul 13, 2022

Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Perfusion CT scan
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Primary and Metastatic Tumors in Renal Cell Carcinoma and

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Immune checkpoint inhibitor targeting PD1
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jan 27, 2023

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

Cadonilimab, Clear Cell Renal Cell Carcinoma, Neoadjuvant Therapy Trial in Guangzhou (Cadonilimab Combined With Lenvatinib)

Recruiting
  • Cadonilimab
  • +2 more
  • Cadonilimab Combined With Lenvatinib
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen University Cancer Center
Nov 16, 2023

Renal Cell Carcinoma Trial in Wuxi (68Ga-NY104)

Recruiting
  • Renal Cell Carcinoma
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Nov 27, 2022

Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

Recruiting
  • Carcinoma
  • +4 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Jun 30, 2023

    PET/MR for Characterization of Renal Masses (RMs)

    Recruiting
    • Renal Tumor
    • +2 more
    • 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Oct 5, 2023

    Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +1 more
    Dec 14, 2022

    Clear Cell Renal Cell Carcinoma, Solid Tumors Trial (AB521)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • Solid Tumors
    • (no location specified)
    Sep 7, 2022

    Non-Functioning Kidney, Renal Cell Carcinoma Trial (Laparoscopic Surgery)

    Not yet recruiting
    • Non-Functioning Kidney
    • Renal Cell Carcinoma
    • Laparoscopic Surgery
    • (no location specified)
    Nov 11, 2023

    NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +3 more
    • QEQ278
    • (no location specified)
    Jul 14, 2022

    CaboCHECK - Cabozantinib in Adult Advanced Renal Cell Carcinoma

    Terminated
    • Advanced Renal Cell Carcinoma (All Subtypes)
    • Metastatic Renal Cell Carcinoma (All Subtypes)
    • Documentation
    • Essen, Nordrhein-Westfalen, Germany
    • +1 more
    Dec 21, 2022

    Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

    Active, not recruiting
    • Renal Clear Cell Carcinoma
    • Renal Papillary Cell Carcinoma
    • London, United Kingdom
      Thomas Powles
    Aug 10, 2022

    Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

    Recruiting
    • Metastatic Clear Cell Renal Carcinoma
    • CT scan
    • Plasma collection
    • Milan, Mi, Italy
      Istituto Tumori
    Mar 13, 2023

    Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic Trial in Iowa City (Selenomethionine (SLM),

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Clear Cell Renal Cell Carcinoma Metastatic
    • Selenomethionine (SLM)
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Sep 19, 2022

    Renal Cell Carcinoma Trial (Pembrolizumab)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Pembrolizumab
    • (no location specified)
    Aug 17, 2022

    Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
    • +1 more
    Oct 11, 2022

    Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 19, 2023